The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...
The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...
The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback